A Randomised Single Blind Study Comparing the Molar ED50 of Levobupivacaine and Molar ED50 of Ropivacaine When Administered as a Femoral Perineural Infusion for Pain Relief After Total Knee Replacement.
Phase of Trial: Phase IV
Latest Information Update: 08 Dec 2017
At a glance
- Drugs Levobupivacaine (Primary) ; Ropivacaine (Primary)
- Indications Postoperative pain
- Focus Therapeutic Use
- 28 Mar 2012 Primary endpoint identified as (Verbal rating scale) as reported by European Clinical Trials Database record.
- 23 Nov 2011 Location (Scotland) added as reported by ClinicalTrials.gov.
- 23 Nov 2011 Company Tenovus added in associations field as reported by United Kingdom Clinical Research Network record.